ProCE Banner Series

Updates in Multiple Myeloma Care: Expert Guidance for the Multidisciplinary Teams in VHA Systems

Join us for this live 1-hour CME/CE/CPE-certified workshop series to learn how healthcare professionals in the community and Veterans Affairs can effectively integrate newly approved treatment options and personalize treatment to optimize outcomes for patients with multiple myeloma.

To Register: Please click the green “Learn More” button below. On the next page, select “Register for Virtual Event.” Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

  ACPE
  | AMA
  | ANCC
Who Should Attend

This program is intended for oncologists, nurses, pharmacists, and other healthcare professionals on the multidisciplinary team in VHA institutions caring for patients with multiple myeloma.

All Events

Updates in Multiple Myeloma Care: Expert Guidance for the Multidisciplinary Teams in VHA Systems

Past Events

November

30

2023

4:30 PM - 5:30 PM Alaska Standard Time Zone (AK)

Virtual

Private Event | Virtual Group, Anchorage, Alaska

January

18

2024

7:30 PM - 8:30 PM Pacific Time (PT)

Virtual

Virtual Event | Host Group in ID, Coeur d'Alene, Idaho

Faculty

ProCE Banner Faculty
Sarah A. Holstein, MD, PhD

Professor of Medicine
Division of Oncology and Hematology
University of Nebraska Medical Center
Omaha, Nebraska

ProCE Banner Faculty
Aaron Rosenberg, MD, MS

Director
Multiple Myeloma and Plasma Cell Diseases Clinic
UC Davis Comprehensive Cancer Center
Division of Malignant Hematology, Cellular Therapy & Transplantation
Associate Professor of Medicine
UC Davis School of Medicine
Sacramento, California

ProCE Banner Faculty
Ashley Rosko

Professor-Clinical
Division of Hematology
The Ohio State University
Medical Director
Oncogeriatrics 
James Comprehensive Cancer Center
Columbus, Ohio

ProCE Banner Faculty
Adriana Rossi, MD

Assistant Professor of Medicine 
Co-Director 
CART Myeloma Program 
Mount Sinai Hospital
New York, New York

ProCE Banner Faculty
Ravi Vij, MD, MBA

Professor of Medicine
Section of BMT and Leukemia
Division of Medical Oncology
Washington University School of Medicine
St Louis, Missouri

 

Topics

Overview of Multiple Myeloma

Determining Risk of Progression

Care Considerations in Newly Diagnosed Myeloma

Strategies for Management of First Relapse and Heavily Pretreated Disease

Managing Adverse Events Associated With Novel Treatments

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ knowledge, confidence, and competence in applying practice-changing clinical data and expert recommendations to integrate the use of currently available therapies for their patients with multiple myeloma. 

Target Audience
This program is intended for oncologists, nurses, pharmacists, and other healthcare professionals on the multidisciplinary team in VHA institutions caring for patients with multiple myeloma. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Initiate timely systemic treatment for appropriate patients based on the latest multiple myeloma diagnostic criteria, staging criteria, and risk factors
  • Develop individualized treatment strategies for patients with newly diagnosed multiple myeloma through consideration of the available clinical data as well as risk assessment, comorbidities, and patient age/fitness and preferences
  • Select optimal therapies for patients with relapsed/refractory multiple myeloma based on individual patient and disease characteristics, as well as response to and tolerance of previous therapies
  • Manage adverse events associated with new or novel multiple myeloma treatments

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: Universal Activity Number: JA4008176-0000-23-242-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC, Sanofi Genzyme, and Takeda Pharmaceuticals U.S.A., Inc.